AdvaMed asks FDA to make changes to improve its draft guidance on non-binding feedback after medical device establishment inspections.
CDER issues a MAPP with policies and procedures for its new Biopharmaceutics Council.
FDA approves B. Braun Medicals 5,000-unit prefilled heparin sodium injection, USP.
Federal Register notice: FDA has announced a 5/16 public meeting entitled Characterizing FDAs Approach to Benefit-Risk Assessment Throughout the Medic...
Federal Register notice: FDA announces a 6/6 Antimicrobial Drugs Advisory Committee meeting to discuss a Global Alliance for TB Drug Development NDA f...
Federal Register notice: FDA proposes to reclassify surgical staplers for internal use from Class 1 (general controls) into Class 2 (special controls)...
FDA issues a draft guidance recommending training, record-keeping, and procedures for voluntary recalls of regulated products.
FDA says it is concerned that Section 505(q) of the Federal Food, Drug, and Cosmetic Act does not discourage submission of citizen petitions intended ...